Suppr超能文献

根除幽门螺杆菌感染对非溃疡性消化不良患者的症状改善作用。

Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.

作者信息

McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones R, Hilditch T

机构信息

Department of Medicine and Therapeutics, Western Infirmary, Glasgow, United Kingdom.

出版信息

N Engl J Med. 1998 Dec 24;339(26):1869-74. doi: 10.1056/NEJM199812243392601.

Abstract

BACKGROUND

The eradication of Helicobacter pylori infection is beneficial in patients with gastric or duodenal ulcers. The value of eradicating the infection in patients with dyspepsia and no evidence of ulcer disease is not known.

METHODS

We performed a randomized, placebo-controlled trial comparing the efficacy of treatment for two weeks with 20 mg of omeprazole orally twice daily, 500 mg of amoxicillin three times daily (with 500 mg of tetracycline three times daily substituted for amoxicillin in patients allergic to penicillin), and 400 mg of metronidazole three times daily (160 patients) with that of omeprazole alone (158 patients) for resolving symptoms of dyspepsia in patients with H. pylori infection but no evidence of ulcer disease on upper gastrointestinal endoscopy. Symptoms were assessed with the Glasgow Dyspepsia Severity Score, with resolution of symptoms defined as a score of 0 or 1 in the preceding six months (maximal score, 20). One year later the patients were assessed to determine the frequency of the resolution of symptoms.

RESULTS

One month after the completion of treatment, 132 of 150 patients (88 percent) in the group assigned to received omeprazole and antibiotics had a negative test for H. pylori, as compared with 7 of 152 (5 percent) in the group assigned to receive omeprazole alone. One year later, dyspepsia had resolved in 33 of 154 patients (21 percent) in the group given omeprazole and antibiotics, as compared with 11 of 154 (7 percent) in the group given omeprazole alone (95 percent confidence interval for the difference, 7 to 22 percent; P<0.001). Among the patients in the group given omeprazole and antibiotics, the symptoms resolved in 26 of the 98 patients (27 percent) who had had symptoms for five years or less, as compared with 7 of the 56 patients (12 percent) who had had symptoms for more than five years (P=0.03).

CONCLUSIONS

In patients with H. pylori infection and nonulcer, or functional, dyspepsia, treatment with omeprazole and antibiotics to eradicate the infection is more likely to resolve symptoms than treatment with omeprazole alone.

摘要

背景

根除幽门螺杆菌感染对胃溃疡或十二指肠溃疡患者有益。对于消化不良且无溃疡病证据的患者,根除该感染的价值尚不清楚。

方法

我们进行了一项随机、安慰剂对照试验,比较了每日口服两次20mg奥美拉唑、每日三次500mg阿莫西林(对青霉素过敏的患者用每日三次500mg四环素替代阿莫西林)和每日三次400mg甲硝唑治疗两周(160例患者)与单用奥美拉唑(158例患者)治疗幽门螺杆菌感染但上消化道内镜检查无溃疡病证据的消化不良患者症状缓解情况。用格拉斯哥消化不良严重程度评分评估症状,症状缓解定义为前六个月评分为0或1(最高评分20)。一年后评估患者以确定症状缓解的频率。

结果

治疗结束后一个月,接受奥美拉唑和抗生素治疗组的150例患者中有132例(88%)幽门螺杆菌检测呈阴性,而单用奥美拉唑组的152例患者中有7例(5%)呈阴性。一年后,接受奥美拉唑和抗生素治疗组的154例患者中有33例(21%)消化不良症状缓解,而单用奥美拉唑组的154例患者中有11例(7%)症状缓解(差异的95%置信区间为7%至22%;P<0.001)。在接受奥美拉唑和抗生素治疗组的患者中,症状持续时间五年或更短的98例患者中有26例(27%)症状缓解,而症状持续时间超过五年的56例患者中有7例(12%)症状缓解(P=0.03)。

结论

对于幽门螺杆菌感染且有非溃疡性或功能性消化不良的患者,用奥美拉唑和抗生素根除感染比单用奥美拉唑更有可能缓解症状。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验